Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Stacy L
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 10-Q: Q2 2024 Earnings Report
Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
Adaptive Biotechnologies | 8-K: Current report
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%), etc.
Adaptive Biotechnologies | DEFA14A: Others
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | 10-Q: Q1 2024 Earnings Report
Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
Adaptive Biotechnologies | ARS: Annual Report to Security Holders
Adaptive Biotechnologies | DEFA14A: Others
Adaptive Biotechnologies | DEF 14A: Definitive information statements
Adaptive Biotechnologies | 8-K: Current report
Adaptive Biotechnologies | 8-K: Current report
Adaptive Biotechnologies | 8-K: Current report
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director NEUPERT PETER M
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Pellini Michael J
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director OWEN KATEY EINTERZ
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director NEUPERT PETER M
No Data
No Data